{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2025-11-03T12:23:52.920465+00:00",
  "news": [
    {
      "title": "Amgen Breaks Ground on $600 Million Center for Science and Innovation in Thousand Oaks, Calif. - Amgen",
      "link": "https://news.google.com/rss/articles/CBMiygFBVV95cUxQcUV1LWMwMmRSZloxZG4tUVJWX0lnRFBPcDFZbTBMUnBqY3NFeHFXcEN0SUxRMktrRXpGOS00M3lhYkJ1Y2w5YmYtYjBSUGtaMllnU2NURHdZaWVSMlNteTFTdk5ybjl5Tl9BTjNYR21iTHV2aklSYURiMS1pbGJjdmtSTnRJeVhkN3ZVTF8zeHdGcmVYNHlQeF8tNzczTTdXMUxDWldsWFAzUlV0SnpIaVVZT0NPM1pia1FWV3FBaWxhcUxEeFowN29R?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiygFBVV95cUxQcUV1LWMwMmRSZloxZG4tUVJWX0lnRFBPcDFZbTBMUnBqY3NFeHFXcEN0SUxRMktrRXpGOS00M3lhYkJ1Y2w5YmYtYjBSUGtaMllnU2NURHdZaWVSMlNteTFTdk5ybjl5Tl9BTjNYR21iTHV2aklSYURiMS1pbGJjdmtSTnRJeVhkN3ZVTF8zeHdGcmVYNHlQeF8tNzczTTdXMUxDWldsWFAzUlV0SnpIaVVZT0NPM1pia1FWV3FBaWxhcUxEeFowN29R?oc=5\" target=\"_blank\">Amgen Breaks Ground on $600 Million Center for Science and Innovation in Thousand Oaks, Calif.</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Amgen</font>",
      "published": "2025-10-31T17:15:47+00:00",
      "source": "Amgen"
    },
    {
      "title": "Amgen Ventures joins $141M Series B for Italian gene therapy biotech AAVantgarde - Endpoints News",
      "link": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOZWlJVzV0VjRKWHlZVENETTNhY0RUa3Z5bTZITVlGQmJZa3BCNk1VVDRTRWpKQUMtd1FPQm9pUUpld2t4OGVhUmJITHJqeWxIVm1UYXZXQmI0dXRLLWpnTzdqZzFCc2Z5ZzRFUjNkRkhkVmJCRFlMWVBzOXhhZnV5bThRUElTNzRVazJYeWVtWGRCTnVndjRlamtNQVJLT0lLVW9GemJB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipgFBVV95cUxOZWlJVzV0VjRKWHlZVENETTNhY0RUa3Z5bTZITVlGQmJZa3BCNk1VVDRTRWpKQUMtd1FPQm9pUUpld2t4OGVhUmJITHJqeWxIVm1UYXZXQmI0dXRLLWpnTzdqZzFCc2Z5ZzRFUjNkRkhkVmJCRFlMWVBzOXhhZnV5bThRUElTNzRVazJYeWVtWGRCTnVndjRlamtNQVJLT0lLVW9GemJB?oc=5\" target=\"_blank\">Amgen Ventures joins $141M Series B for Italian gene therapy biotech AAVantgarde</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Endpoints News</font>",
      "published": "2025-11-03T08:00:00+00:00",
      "source": "Endpoints News"
    },
    {
      "title": "AMGEN ANNOUNCES 2025 FOURTH QUARTER DIVIDEND - PR Newswire",
      "link": "https://news.google.com/rss/articles/CBMiogFBVV95cUxPUnp3MkxtYlMtczUtNXVTMWQ2eExoeUgtX2NuUWU5eFB3bDhKRTY3WTBXelpSVmlIY2x0SzB6NzJqcVdoa184dmQwVzk4Q0FZWWMtbUVaUHUyVERldFR5dU90ZjF3TElmSVFMeTR2ZDF1RFV4ZEE1REdKd2lVOEdTV2ZtZjUyRHZMQzR1VkRpbWkzWGttQUdBQjNrWlJ3cXZsY1E?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiogFBVV95cUxPUnp3MkxtYlMtczUtNXVTMWQ2eExoeUgtX2NuUWU5eFB3bDhKRTY3WTBXelpSVmlIY2x0SzB6NzJqcVdoa184dmQwVzk4Q0FZWWMtbUVaUHUyVERldFR5dU90ZjF3TElmSVFMeTR2ZDF1RFV4ZEE1REdKd2lVOEdTV2ZtZjUyRHZMQzR1VkRpbWkzWGttQUdBQjNrWlJ3cXZsY1E?oc=5\" target=\"_blank\">AMGEN ANNOUNCES 2025 FOURTH QUARTER DIVIDEND</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PR Newswire</font>",
      "published": "2025-10-31T20:01:00+00:00",
      "source": "PR Newswire"
    },
    {
      "title": "Bank of Montreal Can Cuts Stake in Amgen Inc. $AMGN - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNT2NQbUVIeXpmdC04bFZXd01JcHVMV3hXaEltX1phU29zVDlTdkQ5ZmEtN05JN0FtekRkdlRYbTRWd2J3dXpadEF5LS1sU3NpeG5TSm45MHV6UjdEUnNTaG55MmRxa3Z0ZXNDNWVRejZjYkRFdjYyQ2hOS3JtalFNWTdaQXhjSVgxalZUcUpXSEZ0TTAtLTRjNk5tQm5CemN0MmI4Z1JsTUtPREtJTG9r?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMirwFBVV95cUxNT2NQbUVIeXpmdC04bFZXd01JcHVMV3hXaEltX1phU29zVDlTdkQ5ZmEtN05JN0FtekRkdlRYbTRWd2J3dXpadEF5LS1sU3NpeG5TSm45MHV6UjdEUnNTaG55MmRxa3Z0ZXNDNWVRejZjYkRFdjYyQ2hOS3JtalFNWTdaQXhjSVgxalZUcUpXSEZ0TTAtLTRjNk5tQm5CemN0MmI4Z1JsTUtPREtJTG9r?oc=5\" target=\"_blank\">Bank of Montreal Can Cuts Stake in Amgen Inc. $AMGN</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2025-11-03T11:51:05+00:00",
      "source": "MarketBeat"
    },
    {
      "title": "Amgen Earnings: What To Look For From AMGN - FinancialContent",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPckpYY19RdDI1cTUySjd4UG1FUjVWckhjVEFZRDFBMG5JUFhWazJWTVItZk1DY29OYTZJSDM4ZHBWM3R1MHIwWkN4WnYzRFNtTjNfZDhHZEVvNjQzRW1wY2ltem9QdVlmVmpmUVdsdHZWc2NJeE8xTVZaWHhVLTM2OHFydDZteVF2UVFQSG5jelBQcF90OHQwT2J0UExLVkttZHE1aHFfOVFUZVJzNzBEZ2h3?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxPckpYY19RdDI1cTUySjd4UG1FUjVWckhjVEFZRDFBMG5JUFhWazJWTVItZk1DY29OYTZJSDM4ZHBWM3R1MHIwWkN4WnYzRFNtTjNfZDhHZEVvNjQzRW1wY2ltem9QdVlmVmpmUVdsdHZWc2NJeE8xTVZaWHhVLTM2OHFydDZteVF2UVFQSG5jelBQcF90OHQwT2J0UExLVkttZHE1aHFfOVFUZVJzNzBEZ2h3?oc=5\" target=\"_blank\">Amgen Earnings: What To Look For From AMGN</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">FinancialContent</font>",
      "published": "2025-11-03T03:05:00+00:00",
      "source": "FinancialContent"
    },
    {
      "title": "A Fresh Look at Amgen (AMGN) Valuation After Key EU Drug Approval and Upcoming Clinical Data Releases - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMigwFBVV95cUxPdXV6ZkFTSE1jV2hDZ0I2VlJTRDZvT1Z5T0toZUswZUE1WHk1YVI4dnNncUpBY3BDX0JJejBvdFB3VGx6ejNhaENaeVMtcE9Mc1diWUFIQXZtNVFyT1VId2FIQ2xSMHpyLVk1T0ljbmVCMnR2cXZjVXVIZDNMeHgwUTBVYw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMigwFBVV95cUxPdXV6ZkFTSE1jV2hDZ0I2VlJTRDZvT1Z5T0toZUswZUE1WHk1YVI4dnNncUpBY3BDX0JJejBvdFB3VGx6ejNhaENaeVMtcE9Mc1diWUFIQXZtNVFyT1VId2FIQ2xSMHpyLVk1T0ljbmVCMnR2cXZjVXVIZDNMeHgwUTBVYw?oc=5\" target=\"_blank\">A Fresh Look at Amgen (AMGN) Valuation After Key EU Drug Approval and Upcoming Clinical Data Releases</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-11-02T05:11:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Amgen breaks ground on $600M research and development center in Thousand Oaks - Ventura County Star",
      "link": "https://news.google.com/rss/articles/CBMi5AFBVV95cUxQV3FDUUEyLVNmSDhWYUE0aWZZb3hyZXBnMHZ6cUFYcU01T3Mzb19mTWhnUVJibGJuSVZRME9LSUlGMndNXzFTV3E5VFNWZG9qaXU1eFBxRmxBM1R6WmRKMUhjd21jM21Hd21SUWxzaVkyOEZscGFmN2ozd3RCcDNjTlEtVjRENFgwbFgxUU9KRVkzUG5sNzNwbVBRWGktZ0YxMURZUEV4WUJHS2xrTXpWY1JHX29Kcm1HUjlYa0JmNS0tcTZEVWY0ZjE2bVdSdDFYODI2am5fOHRoUUlORnpTRkVBQ0Q?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi5AFBVV95cUxQV3FDUUEyLVNmSDhWYUE0aWZZb3hyZXBnMHZ6cUFYcU01T3Mzb19mTWhnUVJibGJuSVZRME9LSUlGMndNXzFTV3E5VFNWZG9qaXU1eFBxRmxBM1R6WmRKMUhjd21jM21Hd21SUWxzaVkyOEZscGFmN2ozd3RCcDNjTlEtVjRENFgwbFgxUU9KRVkzUG5sNzNwbVBRWGktZ0YxMURZUEV4WUJHS2xrTXpWY1JHX29Kcm1HUjlYa0JmNS0tcTZEVWY0ZjE2bVdSdDFYODI2am5fOHRoUUlORnpTRkVBQ0Q?oc=5\" target=\"_blank\">Amgen breaks ground on $600M research and development center in Thousand Oaks</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Ventura County Star</font>",
      "published": "2025-10-31T16:53:58+00:00",
      "source": "Ventura County Star"
    },
    {
      "title": "US FDA expands use of Amgen, AstraZeneca's drug for chronic inflammatory sinus disease - Reuters",
      "link": "https://news.google.com/rss/articles/CBMiygFBVV95cUxPdHIxQV8zM2pKOENLQm1ULVdWcXd6b2wzYzhxd3p2aHE5ZTd5RWs0UWx6QTd1VDJ1RXpkbUVUWG1JT3UzSmZrVER6OUVMNFNSZXFGa2FWdmpaVWxsVVl3VFNhS1hydC1YaDgwTDdob3l1dFBFaU9PZTVwUXpsM3AteGZ2ZjhFd2FJYWlfbzFWcUxacFFPOU9rQUNNWXprUUZmTTQwRHpzcjRRZTV0ZEQ3QWdRMkpYNW9GUDlwcnY4d3ROTEE0bS1tZldB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiygFBVV95cUxPdHIxQV8zM2pKOENLQm1ULVdWcXd6b2wzYzhxd3p2aHE5ZTd5RWs0UWx6QTd1VDJ1RXpkbUVUWG1JT3UzSmZrVER6OUVMNFNSZXFGa2FWdmpaVWxsVVl3VFNhS1hydC1YaDgwTDdob3l1dFBFaU9PZTVwUXpsM3AteGZ2ZjhFd2FJYWlfbzFWcUxacFFPOU9rQUNNWXprUUZmTTQwRHpzcjRRZTV0ZEQ3QWdRMkpYNW9GUDlwcnY4d3ROTEE0bS1tZldB?oc=5\" target=\"_blank\">US FDA expands use of Amgen, AstraZeneca's drug for chronic inflammatory sinus disease</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font>",
      "published": "2025-10-17T07:00:00+00:00",
      "source": "Reuters"
    }
  ],
  "product_launches": [
    {
      "title": "A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-10-16T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5\" target=\"_blank\">Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-09-10T07:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "Endo Launches First Generic Version of Amgen’s RAVICTI, Expanding Access for Rare Disease Patients - MyChesCo",
      "link": "https://news.google.com/rss/articles/CBMi7AFBVV95cUxNejJnZmFlNXA2dGd5ZDhMY3JHY25lNW9CNmV2SHkzVThEZ2YtbUp0RHVXYmVRUjUyNzFLc0RicXdCQkl5blVxRWNCbzdxWEFMQ3lHNWlocFc2SFNUcC1hNHZSOGF4aVhJaEtQNzYzMTR2QWxtMXFMMlFGcnV2N0VHNDAzQVFHMUNyTjJuTE5BOEZjdWlZdFMzc2hoUVBPZkRUQnBzUWp4MUk4WFFDRlJQZl9JeEtKbzFHRFl2ZER6WEVMa1E2eFV3RmhtTzZhMUVXdXRBdGpxdThYQklWWHFDTF9rSXNObVo4d0tlbw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi7AFBVV95cUxNejJnZmFlNXA2dGd5ZDhMY3JHY25lNW9CNmV2SHkzVThEZ2YtbUp0RHVXYmVRUjUyNzFLc0RicXdCQkl5blVxRWNCbzdxWEFMQ3lHNWlocFc2SFNUcC1hNHZSOGF4aVhJaEtQNzYzMTR2QWxtMXFMMlFGcnV2N0VHNDAzQVFHMUNyTjJuTE5BOEZjdWlZdFMzc2hoUVBPZkRUQnBzUWp4MUk4WFFDRlJQZl9JeEtKbzFHRFl2ZER6WEVMa1E2eFV3RmhtTzZhMUVXdXRBdGpxdThYQklWWHFDTF9rSXNObVo4d0tlbw?oc=5\" target=\"_blank\">Endo Launches First Generic Version of Amgen’s RAVICTI, Expanding Access for Rare Disease Patients</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MyChesCo</font>",
      "published": "2025-10-27T04:00:00+00:00",
      "source": "MyChesCo"
    },
    {
      "title": "$239/month for Repatha — AmgenNow direct-to-patient program offers nearly 60% discount in U.S. - Stock Titan",
      "link": "https://news.google.com/rss/articles/CBMivgFBVV95cUxNX1VmYlB3RmtYTG5rd1dJblFhNVh6UEFHdzkxTm9VRy0wMVc1SDNuZ0JLYUNRTHA0VVhBOEpWb1RUa2FONTVMY19CSTJSVVJSUjFwbkIwMFdtalFEWHRmQTVvQnFzY3YxYUFqaDc2cjBydnV0RjdSWGhCTzdaWDl1Y2VNVU9LdzZvLW1FZHhnam12Qm1XaEg0M3ZEeTh4aHNkcUZsazNRa0tuTGY3WXNiZjZKSnh2SkJRVVl6OXRR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivgFBVV95cUxNX1VmYlB3RmtYTG5rd1dJblFhNVh6UEFHdzkxTm9VRy0wMVc1SDNuZ0JLYUNRTHA0VVhBOEpWb1RUa2FONTVMY19CSTJSVVJSUjFwbkIwMFdtalFEWHRmQTVvQnFzY3YxYUFqaDc2cjBydnV0RjdSWGhCTzdaWDl1Y2VNVU9LdzZvLW1FZHhnam12Qm1XaEg0M3ZEeTh4aHNkcUZsazNRa0tuTGY3WXNiZjZKSnh2SkJRVVl6OXRR?oc=5\" target=\"_blank\">$239/month for Repatha — AmgenNow direct-to-patient program offers nearly 60% discount in U.S.</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Stock Titan</font>",
      "published": "2025-10-06T07:00:00+00:00",
      "source": "Stock Titan"
    },
    {
      "title": "Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5\" target=\"_blank\">Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-07-15T07:00:00+00:00",
      "source": "Seeking Alpha"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2025-10-31",
      "close": 298.42999267578125
    },
    "history": [
      {
        "date": "2025-10-23",
        "close": 292.8900146484375
      },
      {
        "date": "2025-10-24",
        "close": 291.760009765625
      },
      {
        "date": "2025-10-27",
        "close": 291.1600036621094
      },
      {
        "date": "2025-10-28",
        "close": 292.0899963378906
      },
      {
        "date": "2025-10-29",
        "close": 291.7699890136719
      },
      {
        "date": "2025-10-30",
        "close": 292.0
      },
      {
        "date": "2025-10-31",
        "close": 298.42999267578125
      }
    ],
    "name": "Amgen Inc."
  }
}